loading

BOTANIX PHARMACEUTICALS Stock (BXPHF) Forecast

The BOTANIX PHARMACEUTICALS (BXPHF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0163, representing a +2.10% increase from the current price of $0.016. The highest analyst price target is $0.0317, and the lowest is $0.000996.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BXPHF Price Target
Average 0.0415 (+159.50% Upside)
loading

Is BOTANIX PHARMACEUTICALS (BXPHF) A Buy Now?

Oscillators
Name Value Action
RSI(14) 46.28 Neutral
STOCH(9,6) 15.39 Buy
STOCHRSI(14) 48.35 Neutral
MACD(12,26) -0.00478 Buy
ADX(14) 18.92 Neutral
William %R -86.11 Buy
CCI(14) -51.72 Neutral
Buy: 3 Sell: 0 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
0.019
Sell
0.0171
Sell
MA20
0.021
Sell
0.0204
Sell
MA50
0.0291
Sell
0.0353
Sell
MA100
0.043
Sell
0.00
Buy
MA200
0.0215
Sell
0.00
Buy
Buy: 2 Sell: 8 Neutral: 0
Summary: Sell
According to our latest analysis, BXPHF could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BXPHF, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 46.28 indicates that BXPHF is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 15.39 indicates that BXPHF is oversold. This indicates that BXPHF price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.35 indicates that BXPHF is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 18.92 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -51.72 indicates that BXPHF is still oversold but not to an extreme extent.

Long-term BXPHF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about BOTANIX PHARMACEUTICALS financial reports and earnings history, BOTANIX PHARMACEUTICALS (BXPHF) stock could reach $0.0684 by 2030, $0.5206 by 2040 and $1.1857 by 2050. See the projected annual prices until 2050 of the BOTANIX PHARMACEUTICALS stock below:

  • BOTANIX PHARMACEUTICALS (BXPHF) is expected to reach an average price of $0.2064 in 2035, with a high prediction of $0.2679 and a low estimate of $0.2064. This indicates an $1,190% rise from the last recorded price of $0.016.
  • BOTANIX PHARMACEUTICALS (BXPHF) stock is projected to chart a bullish course in 2040, with an average price target of $0.4431, representing an $2,670% surge from its current level. The forecast ranges from a conservative $0.4431 to a sky-high $0.5206.
  • Our analysts predict BOTANIX PHARMACEUTICALS (BXPHF) to jump 4,426% by 2045, soaring from $0.7266 to an average price of $0.7242, potentially reaching $0.831. While $0.7266 is the low estimate, the potential upside is significant.
  • BOTANIX PHARMACEUTICALS (BXPHF) stock is expected to climb by 2050, reaching an average of $1.0691, a $6,582% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.1857 and $1.0691, respectively, highlighting the market's uncertainty.

BOTANIX PHARMACEUTICALS Stock (BXPHF) Year by Year Forecast

BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2026

The predicted value for BOTANIX PHARMACEUTICALS (BXPHF) in 2026 is set at an average of $0.0579. Estimates vary from a peak of $0.1149 to a trough of $0.000996, indicating an +262.18% surge from the present price of $0.016.
Month Average Low High Change from today's price
November, 2026 $0.0292 $0.000996 $0.0317 +82.22%
December, 2026 $0.0153 $0.00771 $0.0209 -4.37%

BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for BOTANIX PHARMACEUTICALS (BXPHF) is $0.0415, with a high forecast of $0.083 and a low forecast of $0.000009. This indicates an +159.50% increase from the last price of $0.016.
Month Average Low High Change from today's price
January, 2027 $0.0274 $0.0115 $0.0525 +71.05%
February, 2027 $0.0103 $0.0107 $0.0339 -35.54%
March, 2027 $0.0134 $0.0111 $0.0184 -16.14%
April, 2027 $0.0129 $0.0129 $0.0187 -19.37%
May, 2027 $0.00848 $0.00986 $0.0114 -46.98%
June, 2027 $0.000387 $0.000387 $0.0287 -97.58%
July, 2027 $0.00567 $0.00173 $0.0103 -64.56%
August, 2027 $0.0647 $0.000009 $0.0669 +304.27%
September, 2027 $0.0427 $0.0427 $0.0607 +166.81%
October, 2027 $0.0522 $0.0522 $0.083 +226.29%
November, 2027 $0.0477 $0.0352 $0.0486 +198.26%
December, 2027 $0.0616 $0.0238 $0.0596 +285.18%

BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2028

In 2028, BOTANIX PHARMACEUTICALS (BXPHF) is projected to reach an average price of $0.0841, with a high projection of $0.1533 and a low estimate of $0.015. This indicates an +425.87% rise from the last price of $0.016.
Month Average Low High Change from today's price
January, 2028 $0.0301 $0.0609 $0.065 +88.09%
February, 2028 $0.0635 $0.0571 $0.0577 +296.63%
March, 2028 $0.0393 $0.0422 $0.05 +145.42%
April, 2028 $0.0339 $0.0343 $0.0439 +112.08%
May, 2028 $0.0222 $0.0215 $0.0261 +39.00%
June, 2028 $0.1444 $0.015 $0.1498 +802.65%
July, 2028 $0.1303 $0.1245 $0.1372 +714.21%
August, 2028 $0.1177 $0.1145 $0.1533 +635.84%
September, 2028 $0.1069 $0.0976 $0.1126 +568.33%
October, 2028 $0.1165 $0.0799 $0.1087 +627.88%
November, 2028 $0.0751 $0.1062 $0.1115 +369.32%
December, 2028 $0.1021 $0.1006 $0.1003 +538.38%

BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2029

The 2029 price forecast for BOTANIX PHARMACEUTICALS Stock (BXPHF) is $0.1313 on average, with a high prediction of $0.2327 and a low estimate of $0.03. This represents an +720.85% increase from the previous price of $0.016.
Month Average Low High Change from today's price
January, 2029 $0.0701 $0.0746 $0.0871 +337.82%
February, 2029 $0.0584 $0.0634 $0.0715 +265.00%
March, 2029 $0.0442 $0.0412 $0.0471 +176.55%
April, 2029 $0.2187 $0.03 $0.2327 +1,267%
May, 2029 $0.2037 $0.2026 $0.2138 +1,173%
June, 2029 $0.1884 $0.1864 $0.2236 +1,078%
July, 2029 $0.1632 $0.16 $0.1833 +919.75%
August, 2029 $0.1694 $0.1359 $0.1661 +958.47%
September, 2029 $0.1581 $0.1581 $0.1623 +888.16%
October, 2029 $0.1408 $0.1408 $0.1437 +780.13%
November, 2029 $0.0926 $0.107 $0.1242 +478.45%
December, 2029 $0.0912 $0.0912 $0.0991 +469.89%

BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2030

BOTANIX PHARMACEUTICALS Stock (BXPHF) is expected to reach an average price of $0.2217 in 2030, with a high forecast of $0.3985 and a low forecast of $0.045. This signifies an +1,286% surge from the last price of $0.016.
Month Average Low High Change from today's price
January, 2030 $0.0624 $0.0609 $0.0684 +289.98%
February, 2030 $0.30 $0.045 $0.3156 +1,775%
March, 2030 $0.2817 $0.2808 $0.2922 +1,660%
April, 2030 $0.267 $0.2582 $0.2938 +1,569%
May, 2030 $0.224 $0.2223 $0.2555 +1,300%
June, 2030 $0.2295 $0.192 $0.2254 +1,334%
July, 2030 $0.2047 $0.2047 $0.2145 +1,179%
August, 2030 $0.1814 $0.1821 $0.1871 +1,034%
September, 2030 $0.1472 $0.1496 $0.1734 +820.07%
October, 2030 $0.1172 $0.1172 $0.1267 +632.68%
November, 2030 $0.0806 $0.0806 $0.0897 +404.02%
December, 2030 $0.3985 $0.06 $0.3985 +2,391%
Cap:     |  Volume (24h):